These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34730477)

  • 21. Healthcare Utilization and Costs Associated with New-Onset Pain in a Medicare Population.
    Staats PS; Patel K; Gillen EM; Bello T; Epple T; Bilder SM; Wisor D
    Pain Physician; 2022 Dec; 25(9):E1415-E1422. PubMed ID: 36608013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health care costs and utilization prior to diagnosis of antineutrophil cytoplasmic antibody vasculitis in Medicare beneficiaries.
    Huang SP; Li X; Cao B; Nguyen JT; Robinson JE; Derebail VK; Hogan SL; Thorpe CT
    J Manag Care Spec Pharm; 2022 Nov; 28(11):1292-1303. PubMed ID: 36282932
    [No Abstract]   [Full Text] [Related]  

  • 23. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries.
    Hazel-Fernandez L; Li Y; Nero D; Moretz C; Slabaugh L; Meah Y; Baltz J; Patel NC; Bouchard JR
    Am J Manag Care; 2015 Jan; 21(1):e62-70. PubMed ID: 25880269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries.
    Wickwire EM; Tom SE; Scharf SM; Vadlamani A; Bulatao IG; Albrecht JS
    Sleep; 2019 Apr; 42(4):. PubMed ID: 30649500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality outcomes, healthcare resource utilization and costs in Medicare patients with chronic heart failure with reduced ejection fraction with and without a worsening event.
    Mentz RJ; Pulungan Z; Kim S; Yang M; Teigland C; Hilkert R; Djatche LM
    J Med Econ; 2021; 24(1):698-705. PubMed ID: 33900874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Need Phenotypes in Medicare Beneficiaries: Drivers of Variation in Utilization and Outcomes.
    Keeney T; Belanger E; Jones RN; Joyce NR; Meyers DJ; Mor V
    J Am Geriatr Soc; 2020 Jan; 68(1):70-77. PubMed ID: 31454082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic outcomes associated with diagnosed behavioral symptoms among patients with dementia in the United States: a health care claims database analysis.
    Khandker RK; Chekani F; Mirchandani K; Kathe N
    BMC Geriatr; 2023 Feb; 23(1):99. PubMed ID: 36797678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anorexia in Medicare Fee-for-Service Beneficiaries: A Claims-Based Analysis of Epidemiology and Mortality.
    Dagenais S; Fielding RA; Clark S; Cantu C; Prasad S; Groarke JD
    J Nutr Health Aging; 2023; 27(3):184-191. PubMed ID: 36973924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost of cancer management by stage at diagnosis among Medicare beneficiaries.
    Reddy SR; Broder MS; Chang E; Paydar C; Chung KC; Kansal AR
    Curr Med Res Opin; 2022 Aug; 38(8):1285-1294. PubMed ID: 35285354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health Care Resource Utilization and Costs Among Medicare Beneficiaries Newly Diagnosed With Peripheral T-cell Lymphoma: A Retrospective Claims Analysis.
    Shah A; Petrilla A; Rebeira M; Feliciano J; Lisano J; LeBlanc TW
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e1-e9. PubMed ID: 33184000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia.
    Huang Q; Emond B; Lafeuille MH; Gupta D; Lefebvre P; Sundaram M; Mato A
    Curr Med Res Opin; 2020 Dec; 36(12):2009-2018. PubMed ID: 33044848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of health care services among Medicare beneficiaries who visit federally qualified health centers.
    Lavelle TA; Rose AJ; Timbie JW; Setodji CM; Wensky SG; Giuriceo KD; Friedberg MW; Malsberger R; Kahn KL
    BMC Health Serv Res; 2018 Jan; 18(1):41. PubMed ID: 29370837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin biopsy and skin cancer treatment use in the Medicare population, 1993 to 2016.
    Skaggs R; Coldiron B
    J Am Acad Dermatol; 2021 Jan; 84(1):53-59. PubMed ID: 32553682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Claims analysis of Medicare fee-for-service oral health care encounters, from 2019 through 2021.
    Weatherspoon DJ; Hutfless S; Manski RJ
    J Am Dent Assoc; 2023 Nov; 154(11):1000-1007.e1. PubMed ID: 37702636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs.
    Gerds AT; Yu J; Shah A; Xi A; Kumar S; Scherber R; Parasuraman S
    J Med Econ; 2023; 26(1):843-849. PubMed ID: 37294103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Pioneer Accountable Care Organizations vs traditional Medicare fee for service with spending, utilization, and patient experience.
    Nyweide DJ; Lee W; Cuerdon TT; Pham HH; Cox M; Rajkumar R; Conway PH
    JAMA; 2015 Jun; 313(21):2152-61. PubMed ID: 25938875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitis.
    Thorpe CT; Thorpe JM; Jiang T; Atkinson D; Kang Y; Schleiden LJ; Carpenter DM; McGregor JAG; Hogan SL
    Semin Arthritis Rheum; 2018 Feb; 47(4):507-519. PubMed ID: 28918956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and health care utilization of patients suffering from Huntington's disease in Germany: real world evidence based on German claims data.
    Ohlmeier C; Saum KU; Galetzka W; Beier D; Gothe H
    BMC Neurol; 2019 Dec; 19(1):318. PubMed ID: 31823737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.